Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (55)
Rutu Hemani, Ishani Patel, Ninad Inamdar, Gisella Campanelli, Virginia Donovan, Avinash Kumar & Anait S. Levenson. (2022) Dietary Pterostilbene for MTA1-Targeted Interception in High-Risk Premalignant Prostate Cancer. Cancer Prevention Research 15:2, pages 87-100.
Crossref
Crossref
İpek BALIKÇI ÇİÇEK & Zeynep KÜÇÜKAKÇALI. (2020) Classification of Prostate Cancer and Determination of Related Factors with Different Artificial Neural Network. Middle Black Sea Journal of Health Science 6:3, pages 325-332.
Crossref
Crossref
Juliana Felgueiras, Joana Vieira Silva & Margarida Fardilha. (2014) Prostate cancer: the need for biomarkers and new therapeutic targets. Journal of Zhejiang University SCIENCE B 15:1, pages 16-42.
Crossref
Crossref
Liran Zhou, Keiko Hosohata, Shen Gao, Zhongping Gu & Zhengxin Wang. (2013) cGMP-Dependent Protein Kinase Iβ Interacts with p44/WDR77 to Regulate Androgen Receptor-Driven Gene Expression. PLoS ONE 8:6, pages e63119.
Crossref
Crossref
David G Bostwick & Liang Cheng. (2011) Precursors of prostate cancer. Histopathology 60:1, pages 4-27.
Crossref
Crossref
Mark L. Gonzalgo & Alan Keith Meeker. 2012. Campbell-Walsh Urology. Campbell-Walsh Urology
530
567.e16
.
L Shan, L Ambroisine, J Clark, R J Yáñez-Muñoz, G Fisher, S C Kudahetti, J Yang, S Kia, X Mao, A Fletcher, P Flohr, S Edwards, G Attard, J De-Bono, B D Young, C S Foster, V Reuter, H Moller, T D Oliver, D M Berney, P Scardino, J Cuzick, C S Cooper & Y-J Lu. (2010) The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer. Prostate Cancer and Prostatic Diseases 13:2, pages 117-125.
Crossref
Crossref
C S Foster, A R Dodson, L Ambroisine, G Fisher, H Møller, J Clark, G Attard, J De-Bono, P Scardino, V E Reuter, C S Cooper, D M Berney & J Cuzick. (2009) Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement. British Journal of Cancer 101:7, pages 1137-1144.
Crossref
Crossref
Wanzhong Wang, Anders Bergh & Jan‐Erik Damber. (2009) Morphological transition of proliferative inflammatory atrophy to high‐grade intraepithelial neoplasia and cancer in human prostate. The Prostate 69:13, pages 1378-1386.
Crossref
Crossref
DAVID G. BOSTWICK & ISABELLE MEIERS. 2009. Modern Surgical Pathology. Modern Surgical Pathology
1121
1180
.
Raza Ali NaqviArif HussainMohmammad RaishAfshan NoorMohammad ShahidRitu SarinHimani KukretiNida Jameel KhanShandar AhmadSuryanarayan V.S. DeoSyed Akhtar HusainSyed Tazeen PashaSeemi Farhat BasirNootan Kumar Shukla. (2008)
Specific 5′CpG Island Methylation Signatures of
FHIT
and
p16
Genes and Their Potential Diagnostic Relevance in Indian Breast Cancer Patients
. DNA and Cell Biology 27:9, pages 517-525.
Crossref
Crossref
G Attard, J Clark, L Ambroisine, I G Mills, G Fisher, P Flohr, A Reid, S Edwards, G Kovacs, D Berney, C Foster, C E Massie, A Fletcher, J S De Bono, P Scardino, J Cuzick & C S Cooper. (2008) Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer. British Journal of Cancer 99:2, pages 314-320.
Crossref
Crossref
Ole Johan Halvorsen. (2008) Molecular and prognostic markers in prostate cancer. APMIS 116, pages 1-62.
Crossref
Crossref
J Clark, G Attard, S Jhavar, P Flohr, A Reid, J De-Bono, R Eeles, P Scardino, J Cuzick, G Fisher, M D Parker, C S Foster, D Berney, G Kovacs & C S Cooper. (2007) Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene 27:14, pages 1993-2003.
Crossref
Crossref
G Attard, J Clark, L Ambroisine, G Fisher, G Kovacs, P Flohr, D Berney, C S Foster, A Fletcher, W L Gerald, H Moller, V Reuter, J S De Bono, P Scardino, J Cuzick & C S Cooper. (2007) Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene 27:3, pages 253-263.
Crossref
Crossref
Kien T. Mai, Bruce F. Burns, William A. Stinson & Christopher Morash. (2007) The 3-dimensional Structure of Isolated and Small Foci of Prostatic Adenocarcinoma. Applied Immunohistochemistry & Molecular Morphology 15:1, pages 50-55.
Crossref
Crossref
Alan K. Meeker. 2007. Prostate Cancer. Prostate Cancer
317
352
.
Nuno Cerveira, Franclim R. Ribeiro, Ana Peixoto, Vera Costa, Rui Henrique, Carmen Jerönimo & Manuel R. Teixeira. (2006) TMPRSS2-ERG Gene Fusion Causing ERG Overexpression Precedes Chromosome Copy Number Changes in Prostate Carcinomas, Paired HGPIN Lesions. Neoplasia 8:10, pages 826-832.
Crossref
Crossref
Nicoletta Colombo, Franca Formelli, Maria Grazia Cantù, Gabriella Parma, Milena Gasco, Alessandra Argusti, Alfredo Santinelli, Rodolfo Montironi, Elena Cavadini, Laura Baglietto, Aliana Guerrieri-Gonzaga, Giuseppe Viale & Andrea Decensi. (2006) A Phase I-II Preoperative Biomarker Trial of Fenretinide in Ascitic Ovarian Cancer. Cancer Epidemiology, Biomarkers & Prevention 15:10, pages 1914-1919.
Crossref
Crossref
Horacio Murillo, Lucy J. Schmidt, Melissa Karter, Kari A. Hafner, Yasushi Kondo, Karla V. Ballman, George Vasmatzis, Robert B. Jenkins & Donald J. Tindall. (2006) Prostate cancer cells use genetic and epigenetic mechanisms for progression to androgen independence. Genes, Chromosomes and Cancer 45:7, pages 702-716.
Crossref
Crossref
L L Xu, C Sun, G Petrovics, M Makarem, B Furusato, W Zhang, I A Sesterhenn, D G McLeod, L Sun, J W Moul & S Srivastava. (2005) Quantitative expression profile of PSGR in prostate cancer. Prostate Cancer and Prostatic Diseases 9:1, pages 56-61.
Crossref
Crossref
Franclim R. Ribeiro, Chieu B. Diep, Carmen Jerónimo, Rui Henrique, Carlos Lopes, Mette Eknæs, Ole Christian Lingjærde, Ragnhild A. Lothe & Manuel R. Teixeira. (2006) Statistical dissection of genetic pathways involved in prostate carcinogenesis. Genes, Chromosomes and Cancer 45:2, pages 154-163.
Crossref
Crossref
K. Senthilkumar, A. Arunkumar, N. Sridevi, M. R. Vijayababu, P. Kanagaraj, P. Venkataraman, M. M. Aruldhas, N. Srinivasan & J. Arunakaran. (2006) Chemoprevention of MNU and Testosterone induced prostate carcinogenesis by Calcitriol (vitamin D3) in adult male albino Wistar rats. Annals of Cancer Research and Therapy 14:1, pages 12-18.
Crossref
Crossref
Arumugam Arunkumar, Marati Radhakrishnan Vijayababu, Prabhu Venkataraman, Kalimuthu Senthilkumar & Jagadeesan Arunakaran. (2006) Chemoprevention of Rat Prostate Carcinogenesis by Diallyl Disulfide, an Organosulfur Compound of Garlic. Biological and Pharmaceutical Bulletin 29:2, pages 375-379.
Crossref
Crossref
H. Bonkhoff & T. Fixemer. (2005) Bedeutung der Östrogene und ihrer Rezeptoren für die Entstehung und Progression des ProstatakarzinomsImplications of estrogens and their receptors for the development and progression of prostate cancer. Der Pathologe 26:6, pages 461-468.
Crossref
Crossref
Hanna Kim, Jacques Lapointe, Gulsah Kaygusuz, David E. Ong, Chunde Li, Matt van de Rijn, James D. Brooks & Jonathan R. Pollack. (2005)
The Retinoic Acid Synthesis Gene
ALDH1a2
Is a Candidate Tumor Suppressor in Prostate Cancer
. Cancer Research 65:18, pages 8118-8124.
Crossref
Crossref
L Zeng & N Kyprianou. (2004) Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention. Prostate Cancer and Prostatic Diseases 8:1, pages 7-13.
Crossref
Crossref
Donald Earl Henson & Jorge Albores-Saavedra. 2005. Cancer Chemoprevention. Cancer Chemoprevention
69
96
.
Srinivasan Yegnasubramanian & William G. Nelson. 2005. DNA Methylation, Epigenetics and Metastasis. DNA Methylation, Epigenetics and Metastasis
45
79
.
Carmen Jerónimo, Rui Henrique, Mohammad O. Hoque, Elizabeth Mambo, Franclim R. Ribeiro, Graça Varzim, Jorge Oliveira, Manuel R. Teixeira, Carlos Lopes & David Sidransky. (2004) A Quantitative Promoter Methylation Profile of Prostate Cancer. Clinical Cancer Research 10:24, pages 8472-8478.
Crossref
Crossref
Veeresa Gududuru, Eunju Hurh, James T. Dalton & Duane D. Miller. (2004) Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer. Bioorganic & Medicinal Chemistry Letters 14:21, pages 5289-5293.
Crossref
Crossref
Christopher S Foster, Alison Falconer, Andrew R Dodson, Andrew R Norman, Nening Dennis, Anne Fletcher, Christine Southgate, Anna Dowe, David Dearnaley, Sameer Jhavar, Rosalind Eeles, Andrew Feber & Colin S Cooper. (2004) Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome. Oncogene 23:35, pages 5871-5879.
Crossref
Crossref
Christopher Foster, Vasilliki Karavana, Youqiang Ke & Mustafa Djamgoz. 2004. Disorders of the Prostate. Disorders of the Prostate
21
47
.
Eric Deutsch, Laurence Maggiorella, Pascal Eschwege, Jean Bourhis, Jean Charles Soria & Bassam Abdulkarim. (2004) Environmental, genetic, and molecular features of prostate cancer. The Lancet Oncology 5:5, pages 303-313.
Crossref
Crossref
M Slater, S Danieletto, A Gidley-Baird, L C Teh & J A Barden. (2004) Early prostate cancer detected using expression of non-functional cytolytic P2X7 receptors. Histopathology 44:3, pages 206-215.
Crossref
Crossref
David G Bostwick & Junqi Qian. (2004) High-grade prostatic intraepithelial neoplasia. Modern Pathology 17:3, pages 360-379.
Crossref
Crossref
Mikio Yamanaka, Masatoshi Watanabe, Yasushi Yamada, Akimitsu Takagi, Tetsuya Murata, Hiroyuki Takahashi, Hiroyoshi Suzuki, Haruo Ito, Hiromasa Tsukino, Takahiko Katoh, Yoshiki Sugimura & Taizo Shiraishi. (2003) Altered methylation of multiple genes in carcinogenesis of the prostate. International Journal of Cancer 106:3, pages 382-387.
Crossref
Crossref
Athanase Billis & Luis A. Magna. (2003) Inflammatory Atrophy of the Prostate. Archives of Pathology & Laboratory Medicine 127:7, pages 840-844.
Crossref
Crossref
Bisera Vukovic, Paul C Park, Jaudah Al-Maghrabi, Ben Beheshti, Joan Sweet, Andy Evans, John Trachtenberg & Jeremy Squire. (2003) Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma. Oncogene 22:13, pages 1978-1987.
Crossref
Crossref
Rebecca L. Fouts, George E. Sandusky, Shaobo Zhang, George J. Eckert, Michael O. Koch, Thomas M. Ulbright, John N. Eble & Liang Cheng. (2003) Down‐regulation of fragile histidine triad expression in prostate carcinoma. Cancer 97:6, pages 1447-1452.
Crossref
Crossref
Michael D Slater, Christopher Lauer, Angus Gidley-Baird & Julian A Barden. (2003) Markers for the development of early prostate cancer. The Journal of Pathology 199:3, pages 368-377.
Crossref
Crossref
Thomas Fixemer, Klaus Remberger & Helmut Bonkhoff. (2002) Differential expression of the estrogen receptor beta (ERβ) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma. The Prostate 54:2, pages 79-87.
Crossref
Crossref
Mitchell S. Steiner & David G. Bostwick. 2003. Prostate Cancer. Prostate Cancer
35
43
.
H. Bonkhoff. 2003. Prostate Cancer. Prostate Cancer
3
12
.
Arthur R. Brothman. (2002) Cytogenetics and molecular genetics of cancer of the prostate. American Journal of Medical Genetics 115:3, pages 150-156.
Crossref
Crossref
Chiang Wang, Ida M McCarty, Louisa Balazs, Yi Li & Mitchell S Steiner. (2002) Immunohistological detection of BRAF25 in human prostate tumor and cancer specimens. Biochemical and Biophysical Research Communications 295:1, pages 136-141.
Crossref
Crossref
C. S. Foster, A. Dodson, V. Karavana, P. H. Smith & Y. Ke. (2002) Prostatic stem cells. The Journal of Pathology 197:4, pages 551-565.
Crossref
Crossref
RODOLFO MONTIRONI, ROBERTA MAZZUCCHELLI & MARINA SCARPELLI. (2006) Precancerous Lesions and Conditions of the Prostate. Annals of the New York Academy of Sciences 963:1, pages 169-184.
Crossref
Crossref
Nizar K. Wehbi, Ashley L. Dugger, Rebecca B. Bonner, Jan V. Pitha, Robert E. Hurst & George P. HemstreetIIIIII. (2002) Pan-Cadherin as a High Level Phenotypic Biomarker for Prostate Cancer. The Journal of Urology, pages 2215-2221.
Crossref
Crossref
Nizar K. Wehbi, Ashley L. Dugger, Rebecca B. Bonner, Jan V. Pitha, Robert E. Hurst & George P. Hemstreet. (2002) Pan-Cadherin as a High Level Phenotypic Biomarker for Prostate Cancer. Journal of Urology 167:5, pages 2215-2221.
Crossref
Crossref
Marijana Lijovic, Gino Somers & Albert G. Frauman. (2002) KAI1/CD82 protein expression in primary prostate cancer and in BPH associated with cancer. Cancer Detection and Prevention 26:1, pages 69-77.
Crossref
Crossref
Abraham NyskaAnthony Dayan & Robert R. Maronpot. (2016) New Tools in Therapeutic Research—Prostatic Cancer and Models. Toxicologic Pathology 30:2, pages 283-287.
Crossref
Crossref
Kien T. Mai, Denise C. Landry, Hossein M. Yazdi, William A. Stinson, D. Garth Perkins & Christopher Morash. (2002) Identification of Isolated and Early Prostatic Adenocarcinoma in Radical Prostatectomy Specimens with Correlation to Biopsy Cores: Clinical and Pathogenetic Significance. Pathology - Research and Practice 198:10, pages 655-663.
Crossref
Crossref
Michael D. Slater, Christopher Lauer, Angus Gidley-Baird & Julian A. Barden. 2002. Molecular Pathology, Colorectal Carcinoma, and Prostate Carcinoma. Molecular Pathology, Colorectal Carcinoma, and Prostate Carcinoma
335
345
.
C.S. Foster & W.A. Sakr. (2001) Proliferative lesions of the prostate that mimic carcinoma. Current Diagnostic Pathology 7:3, pages 194-212.
Crossref
Crossref